Frontier Scientific Solutions has commenced construction of its cGMP temperature-controlled facilities at Wilmington International Airport (ILM), and the project has already seen the installation of its first vertical structures. This endeavor aims to become the largest GMP temperature-controlled facility exclusively dedicated to the life sciences sector in North America.

The facility is designed to enhance the efficiency and security of transporting time and temperature-sensitive pharmaceutical and biopharmaceutical products. It will play a crucial role in establishing a direct global gateway for life sciences, connecting North America and Europe with speed and reliability.

Leandro Moreira, COO of Frontier Scientific Solutions, said, “We are thrilled to see our vision come to life with the construction of this monumental facility. It represents a significant leap forward in our mission to revolutionize the life sciences supply chain. By providing the largest GMP temperature-controlled space in North America, we are not only enhancing operational efficiencies but also ensuring that critical healthcare products reach patients in need without delay.”

The Wilmington facility will offer advanced features, including streamlined customs processing through its Free Trade Zone (FTZ) designation, which will allow for duty deferral and operational efficiencies that are vital for the secure distribution of life sciences products across international borders. This strategic advantage will significantly reduce the risk of product loss while promoting sustainability in the supply chain.

Also, as construction progresses, Frontier Scientific Solutions is dedicated to fostering collaboration with local communities and stakeholders, ensuring that the facility not only meets the needs of the life sciences sector but also contributes positively to the Wilmington area.